Does comorbidity affect the benefit of intensive glycemic control in older patients with type 2 diabetes mellitus?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 5, Issue 2, 2009, Pages 78-79

  Saudek, Christopher D ^a,b,c   Kalyani, Rita R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins Diabetes Center   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

COMORBIDITY; COMPUTER ANALYSIS; DISEASE DURATION; FUNCTIONAL STATUS; GLYCEMIC CONTROL; HUMAN; MEDICAL DECISION MAKING; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; THEORETICAL MODEL;

EID: 58849134122     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet1041     Document Type: Note

References (6)

1. Huang ES et al. (2008) The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 149: 11-19
2. Eastman RC et al. (1997) Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 20: 725-734
3. Klein R and Moss S (1995) A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 155: 745-754
4. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853
5. Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559
6. American Diabetes Association et al. (2008) Standards of medical care in diabetes - 2008. Diabetes Care 31 (Suppl 1): S12-S54